catechin has been researched along with Cardiomyopathy, Congestive in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canto, P; Coral-Vázquez, RM; De Los Santos, S; Palma-Flores, C; Zentella-Dehesa, A | 1 |
Bayliss, CR; Dos Remedios, C; El-Mezgueldi, M; Leung, MC; Marston, SB; Messer, AE; Papadaki, M; Redwood, CS; Ward, DG | 1 |
2 other study(ies) available for catechin and Cardiomyopathy, Congestive
Article | Year |
---|---|
(-)-Epicatechin inhibits development of dilated cardiomyopathy in δ sarcoglycan null mouse.
Topics: Animals; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Catechin; Coronary Vessels; Disease Models, Animal; Fibrosis; Male; Mice, Knockout; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sarcoglycans; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstriction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Catechin; Dose-Response Relationship, Drug; Heart; Humans; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phosphorylation; Recombinant Proteins; Troponin I; Troponin T | 2016 |